Cancer Therapy News and Research

RSS

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

14 May 2018

Study gives insight into how signals enter cancer cells and drive aggressive growth

The outside of a cancer cell is bombarded by signals. They come from the immune system, supporting tissues and other structures. But how do those signals impact cancer?

14 May 2018

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated.

11 May 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

11 May 2018

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a simple blood test.

10 May 2018

Early intervention highly effective in reversing lymphedema

A study conducted by researchers at The University of Kansas Cancer Center has found that early, ongoing screening of lymphatic function and immediate patient-administered therapies are highly effective in improving outcomes for women at high risk for breast cancer related lymphedema.

10 May 2018

Scientists identify mutation that makes tumor cells resistant to breast and ovarian cancer drug

Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment olaparib and other PARP inhibitors.

10 May 2018

HCI announces opening of Center for HOPE for improving health among underserved populations

Huntsman Cancer Institute at the University of Utah today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity, a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

New microfluidic device captures tumor-specific EVs to guide cancer diagnosis and treatment

Precision cancer treatment relies on obtaining molecular information about the tumor to guide effective treatment decisions.

8 May 2018

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Today physicians are still severely hampered by the lack of precision of the needle tip location during a biopsy. Looking at lung cancers, 25% of the diagnoses suffer a false negative outcome through traditional biopsy methods. In the future, this can be avoided: for the first time, the European project InSPECT developed miniature spectrometers with integrated light sources enabling guided sensing.

8 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

New immunotherapy treatments offer a remarkable chance for survival for patients with advanced melanoma and hard-to-treat cancers of the bladder, kidney and lung.

4 May 2018

Researchers characterize new protein that plays key role in genetic stability of cells

Researchers from the Novo Nordisk Foundation Center for Protein Research at the Faculty of Health and Medical Sciences have characterized a new protein that is important to the genetic stability of our cells.

3 May 2018

Math provides new insights into how living cells 'think'

How does the 'brain' of a living cell work, allowing an organism to function and thrive in changing and unfavorable environments?

3 May 2018

Project MOVE offers 'action grants' to increase physical activity among breast cancer survivors

Physical activity is an effective way to help improve the many mental and physical side effects of breast cancer treatment.

3 May 2018

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to how primed patients' immune systems are before the therapy is administered.

30 Apr 2018

Specific type of RNA editing plays key role in protein variation in cancer cells, shows research

A multi-center study led by The University of Texas MD Anderson Cancer Center has shed light on why proteins, the seedlings that serve as the incubator for many cancers, can vary from cancer to cancer and even patient to patient, a discovery that adds to a growing base of knowledge important for developing more effective precision therapies.

27 Apr 2018

New CAR-T therapy could provide safer, more effective cancer treatment

There have been few cancer treatments with such a promising future as using the patient's own immune system.

27 Apr 2018

Study finds myeloma precursor disease in 9/11 firefighters

A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead to the blood cancer multiple myeloma.

26 Apr 2018

Cancer Therapy News and Research

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

Study gives insight into how signals enter cancer cells and drive aggressive growth

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Oral drug reduces venous thromboembolism recurrence among cancer patients

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

Early intervention highly effective in reversing lymphedema

Scientists identify mutation that makes tumor cells resistant to breast and ovarian cancer drug

HCI announces opening of Center for HOPE for improving health among underserved populations

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

New microfluidic device captures tumor-specific EVs to guide cancer diagnosis and treatment

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

Researchers characterize new protein that plays key role in genetic stability of cells

Math provides new insights into how living cells 'think'

Project MOVE offers 'action grants' to increase physical activity among breast cancer survivors

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Specific type of RNA editing plays key role in protein variation in cancer cells, shows research

New CAR-T therapy could provide safer, more effective cancer treatment

Study finds myeloma precursor disease in 9/11 firefighters

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News